Are you attending the virtual @UBS Global Healthcare Conference this week? Be sure to catch our CEO Jeff Goater discuss our lead programs, SRF617 (targeting CD39) and SRF388 (targeting IL-27), on Wed, May 20 at 10 a.m. EDT. More: https://t.co/YGAoVJd4W7 #biotech #immunooncology https://t.co/yxpxiLlGBA